Getachew Mengistu
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $492.09 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $187.91 | 10 | $0 (2024) |
| ABBVIE INC. | $112.27 | 6 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $66.14 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $30.78 | 1 | $0 (2023) |
| Fisher & Paykel Healthcare Inc | $26.41 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $20.26 | 1 | $0 (2024) |
| Smith+Nephew, Inc. | $19.88 | 1 | $0 (2022) |
| Gilead Sciences, Inc. | $16.14 | 1 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $12.30 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $225.37 | 11 | Janssen Pharmaceuticals, Inc ($66.91) |
| 2023 | $145.59 | 7 | Janssen Pharmaceuticals, Inc ($75.70) |
| 2022 | $85.69 | 5 | Janssen Pharmaceuticals, Inc ($32.15) |
| 2021 | $22.29 | 1 | AbbVie Inc. ($22.29) |
| 2019 | $13.15 | 1 | Janssen Pharmaceuticals, Inc ($13.15) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/09/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/27/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.43 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/01/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/20/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO, AVYCAZ | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/27/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $24.05 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/04/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: COVID-19 | ||||||
| 02/02/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/12/2024 | Fisher & Paykel Healthcare Inc | FISHER & PAYKEL HEALTHCARE (Device), FISHER & PAYKEL HEALTHCARE, FISHER & PAYKEL HEALTHCARE | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: Nasal High Flow | ||||||
| 11/30/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $23.66 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/11/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/24/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/17/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/13/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $30.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/10/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/12/2023 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/08/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: ANTIBIOTIC | ||||||
| 02/18/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/11/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/28/2022 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/10/2022 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Pharma Products | ||||||
| 10/12/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 723 | 1,194 | $1.0M | $102,717 |
| 2022 | 7 | 860 | 1,448 | $1.3M | $124,711 |
| 2021 | 6 | 864 | 1,537 | $1.3M | $126,079 |
| 2020 | 8 | 885 | 1,623 | $1.3M | $145,854 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 286 | 600 | $400,242 | $40,585 | 10.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 182 | 335 | $323,154 | $34,219 | 10.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 179 | 183 | $173,819 | $17,638 | 10.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 58 | 58 | $108,675 | $8,317 | 7.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $22,779 | $1,958 | 8.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 343 | 759 | $729,297 | $67,885 | 9.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 215 | 377 | $251,485 | $22,803 | 9.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 156 | 159 | $151,203 | $14,621 | 9.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 53 | 53 | $99,252 | $9,102 | 9.2% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 34 | 34 | $58,370 | $4,977 | 8.5% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 38 | 45 | $43,618 | $3,988 | 9.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 21 | 21 | $14,146 | $1,335 | 9.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 305 | 719 | $673,379 | $64,816 | 9.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 248 | 494 | $319,939 | $30,860 | 9.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 224 | 229 | $221,012 | $21,693 | 9.8% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2021 | 40 | 48 | $45,259 | $4,361 | 9.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 36 | 36 | $23,544 | $2,364 | 10.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 11 | 11 | $20,010 | $1,986 | 9.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 340 | 914 | $809,483 | $86,713 | 10.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 223 | 225 | $185,344 | $21,644 | 11.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 178 | 338 | $160,298 | $21,259 | 13.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 35 | 36 | $60,797 | $6,545 | 10.8% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2020 | 30 | 31 | $27,328 | $2,950 | 10.8% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 18 | 18 | $27,272 | $2,901 | 10.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 46 | 46 | $24,439 | $2,874 | 11.8% |
About Getachew Mengistu
Getachew Mengistu is a Student in an Organized Health Care Education/Training Program healthcare provider based in Annapolis, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2015. The National Provider Identifier (NPI) number assigned to this provider is 1427445378.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Getachew Mengistu has received a total of $492.09 in payments from pharmaceutical and medical device companies, with $225.37 received in 2024. These payments were reported across 25 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($492.09).
As a Medicare-enrolled provider, Mengistu has provided services to 3,332 Medicare beneficiaries, totaling 5,802 services with total Medicare billing of $499,361. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Internal Medicine
- Location Annapolis, MD
- Active Since 04/17/2015
- Last Updated 12/01/2018
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1427445378
Products in Payments
- XARELTO (Drug) $187.91
- LifeVest (Device) $66.14
- DALVANCE (Drug) $56.46
- AVYCAZ (Drug) $55.81
- ENTRESTO (Drug) $30.78
- FISHER & PAYKEL HEALTHCARE (Device) $26.41
- DIFICID (Drug) $20.26
- COLLAGENASE SANTYL (Drug) $19.88
- Veklury (Drug) $16.14
- NUZYRA (Drug) $12.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Annapolis
Dr. Igor Belyansky, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $645,870
Juddson Chason, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $20,881
Mary Holthaus, Pa, PA
Student in an Organized Health Care Education/Training Program — Payments: $11,376
Samip Patel, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $10,231
Kari Bailey, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $6,236
Sadia Shafi
Student in an Organized Health Care Education/Training Program — Payments: $4,764